COLLEGIUM PHARMACEUTICAL, INC — Investor Relations & Filings
Filings indexed
821
across all filing types
Latest filing
2020-07-14
Director's Dealing
Country
US
United States of America
Listing
US
COLL
Collegium Pharmaceutical, Inc. is a diversified biopharmaceutical company that develops and commercializes medicines for people with serious medical conditions. The company is focused on building a portfolio of differentiated medications. Its primary area of expertise is in pain management, where it develops products with abuse-deterrent properties designed to be safer alternatives for patients and the community.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| PRIMARY DOCUMENT | 2020-07-14 | English | |
| FORM 8-K | 2020-07-09 | English | |
| PRIMARY DOCUMENT | 2020-07-02 | English | |
| PRIMARY DOCUMENT | 2020-06-03 | English | |
| PRIMARY DOCUMENT | 2020-05-22 | English | |
| PRIMARY DOCUMENT | 2020-05-22 | English |
Browse filings by year
20 years- 2026 21 filings
- 2025 110 filings
- 2024 75 filings
- 2023 56 filings
- 2022 69 filings
- 2021 70 filings
- 2020 84 filings
- 2019 72 filings
- 2018 70 filings
- 2017 59 filings
- 2016 62 filings
- 2015 64 filings
- 2013 1 filing
- 2012 1 filing
- 2010 1 filing
- 2008 1 filing
- 2007 2 filings
- 2006 1 filing
- 2005 1 filing
- 2003 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2020
15 filings
| |||||
| 11629130 | PRIMARY DOCUMENT | 2020-07-14 | English | ||
| 11629131 | FORM 8-K | 2020-07-09 | English | ||
| 11629132 | PRIMARY DOCUMENT | 2020-07-02 | English | ||
| 11629133 | PRIMARY DOCUMENT | 2020-06-03 | English | ||
| 11629134 | PRIMARY DOCUMENT | 2020-05-22 | English | ||
| 11629135 | PRIMARY DOCUMENT | 2020-05-22 | English | ||
| 11629136 | PRIMARY DOCUMENT | 2020-05-22 | English | ||
| 11629137 | PRIMARY DOCUMENT | 2020-05-22 | English | ||
| 11629138 | PRIMARY DOCUMENT | 2020-05-22 | English | ||
| 11629139 | PRIMARY DOCUMENT | 2020-05-22 | English | ||
| 11629140 | PRIMARY DOCUMENT | 2020-05-22 | English | ||
| 11629141 | PRIMARY DOCUMENT | 2020-05-22 | English | ||
| 11629142 | FORM 8-K | 2020-05-22 | English | ||
| 11629143 | PRIMARY DOCUMENT | 2020-05-20 | English | ||
| 11629145 | PRIMARY DOCUMENT | 2020-05-15 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
COLLEGIUM PHARMACEUTICAL, INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32163/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32163 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32163 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32163 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32163}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for COLLEGIUM PHARMACEUTICAL, INC (id: 32163)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.